Save the Date for UMDF Mitochondrial Medicine 2026 - June 17-20 in Orlando, Florida.
Next Webcast will be October 13, 2025
Moderator: Philip Yeske, PhD
Diagnosing and Managing Mitochondrial Disease in Malaysia
Speakers/Panelists:
- Rifhan Azwani Binti Mazlan, Genetic Counsellor, University of Malaya Medical Centre
- Sharifah Azween Binti Syed Omar, Genetic Counsellor, Hospital Pakar Kanak and Universiti Kebangsaan Malaysia (UKM)
Time: 12:00pm ET/11:00am CT/9:00a PT and 6:00pm CET
Looking Ahead...
October 13 - 12pm ET
Topic: Diagnosing and Managing Mitochondrial Disease in Malaysia
Speakers/Panelists:
- Rifhan Azwani Binti Mazlan, Genetic Counsellor, University of Malaya Medical Centre
- Sharifah Azween Binti Syed Omar, Genetic Counsellor, Hospital Pakar Kanak and Universiti Kebangsaan Malaysia (UKM)
November 10 - 12pm ET
Topic: Preclinical Background to Mesangioblast Therapy and Initial Human Studies Information (draft title)
Speakers/Panelists:
- Bert Smeets, PhD, Maastricht University, Netherlands
- Florence Tienen, PhD, Maastricht University, Netherlands
December 8 - 12pm ET
Topic: Clinical Trial Updates
Watch Past UMDF Bench-to-Bedside Seminars
Friday, September 5, 2025
Special MRT Bench-to-Bedside Webcast
Moderators: Philip E. Yeske, PhD and Michio Hirano, MD
Sean Murray, Mito Foundation CEO
Clare Stuart, Mito Foundation Policy and Advocacy Manager
Clair Wright, Lily Foundation
Michio Hirano, MD, Columbia University Medical Center
Dieter Egli, PhD, Columbia Stem Cell Initiative
Robert McFarland, MA MBBS PhD MRCP MRCPH, Director of the NHS Highly Specialised Service for Rare Mitochondrial Disorders
Mary Herbert, PhD, Monash Biomedicine Discovery Institute
Louise Hyslop, NHS
Monday, September 8, 2025
Moderator: Eliza Gordon-Lipkin, MD, National Genome Research Institute
Watch The Role of Rehabilitation Medicine in the Care of Children with Mitochondrial Disease
Dr. Afua Asante-Otoo, MD, FAAPMR, National Institutes of Health, Staff Clinician / Pediatric Physiatrist, Rehabilitation Medicine Department
Hanna Hildenbrand, MS, OTR/L, National Institutes of Health, Occupational Therapist, Rehabilitation Medicine Department
Dr. Minal Jain, PT, DSc, FAPTA, National Institutes of Health, Acting Chief Physical Therapy Section, Rehabilitation Medicine Department
Beth Solomon, MS, CCC-SLP, National Institutes of Health, Senior Lead Speech-Language Pathologist, Rehabilitation Medicine Department
Monday, May 12, 2025
Moderator: Philip E. Yeske, PhD
Watch Chair Highlights for Upcoming UMDF Mito Med 2025
Jonathan R. Brestoff, MD, PhD, MPH, Washington University School of Medicine, St. Louis, MO
Michio Hirano, MD, Columbia University, New York, NY
Natalie M. Niemi, PhD, Washington University School of Medicine, St. Louis, MO
David J. Pagliarini, PhD, Washington University School of Medicine, St. Louis, MO
Fernando Scaglia, MD, Baylor College of Medicine, Houston, TX
Monday, April 14, 2025
Moderator: Fernando Scaglia, MD
Watch Mitochondrial Genetics and Use of Biomarkers for Mitochondrial Disease
Clinical Diagnostic Testing of mtDNA genome for Primary Mitochondrial Disease - Jing Wang, MD, FACMG, ASCP (MB), Children's Hospital of Philadelphia, PA
Use of Biomarkers for Mitochondrial Disease (GDF15, neurofilament light chain, and potentially FGF21 and gelsolin) - Devin Oglesbee, PhD, Mayo Clinic, Rochester, MN
Monday, March 10, 2025
Moderators: Philip Yeske, PhD and Zarazuela Zolkipli Cunningham, MD
Dr. Zuela Zolkipli Cunningham and the CHOP team to provide results from 2023-2024 and what to expect in 2025
Dr. Damiano Zanotto - Insoles update from 2024 CRP
Dr. Tony Adams to review the Gentle Jogger - NEW for the CRP in 2025
Dr. Philip Yeske and Nicole Wilson, UMDF Program Manager - mitoSHARE and COMBINEDBrain
Monday, February 10, 2025
Moderator: Michio Hirano, MD
Overview of Mitochondrial DNA Replication Disorders (MDDS): Genetics, Biochemical Mechanisms and Therapy Approaches - Ramon Martí, PhD, Group Leader, Research Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute (VHIR) and CIBERER, Barcelona (Catalonia)
Preclinical Efficacy and Genetic Safety Studies of Deoxynucleoside Therapy for MDDS - Javier Ramón, PhD, Postdoctoral Researcher, Research Group on Neuromuscular and Mitochondrial Diseases, Vall d’Hebron Research Institute (VHIR) and CIBERER, Barcelona (Catalonia)
Bridging Research and Practice: Clinical Perspectives, Biomarkers, and Treatment Outcomes - Cristina Domínguez González, PhD, Department of Neurology, Neuromuscular Unit, Hospital 12 de Octubre. i+12 Research Institute, CIBERER, Madrid, Spain
Monday, January 13, 2025
Moderators: Amel Karaa, MD and Philip Yeske, PhD
Ingrid Tein, BSc, MD, FRCP(C) - Hospital for Sick Children (SickKids), Toronto, CA
Fernando Scaglia, MD - Baylor College of Medicine, Houston, TX
Jan Smeitink, MD, PhD - Khondrion
Chad Glasser, PharmD, MPH - Tisento Therapeutics
Magnus Hansson, MD, PhD - Abliva
Monday, December 9, 2024
Moderators: Amel Karaa, MD and Philip Yeske, PhD
Watch Clinical Trial Updates - Part 1
Natalie Yivgi Ohana, PhD - Minovia Therapeutics
Robert Fischer, MD, PhD - OMEICOS
Patrice Rioux, MD, PhD - Thiogenesis Therapeutics
Vijay Modur, MD, PhD - BPGbio Inc.
Sharon Hamm, Pharm D - Saol Therapeutics
Susan VanMeter, MD - UCB
Katie Landes, Executive Director - Stealth BioTherapeutics
We are excited to announce the launch of the MitoU Seminar Network. Beginning in January of 2023, the UMDF along with MitoTalks and the Center for Mitochondrial and Epigenomic Medicine will continue to share information about upcoming seminars right here - all in one location.
Visit umdf.org/seminars to view all meetings.